Antihyperlipidemic effects of mushroom extracts and compounds

Mushrooms: Cultivation, Antioxidant Properties and Health Benefits

Volumn , Issue , 2014, Pages 189-198

  Ng, Tzi Bun ^a   Ng, Charlene Cheuk Wing ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Cholesterol; Mushroom; Triglyceride

Indexed keywords

EID: 84948955127     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (34)

1. Abrams DI, Couey P, Shade SB, Kelly ME, Kamanu-Elias N, Stamets P. Antihyperlipidemic effects of Pleurotus ostreatus (oyster mushrooms) in HIV-infected individuals taking antiretroviral therapy. BMC Complement Altern Med. 2011;11:60.
2. Alam N, Yoon KN, Lee TS. Antihyperlipidemic activities of Pleurotus ferulae on biochemical and histological function in hypercholesterolemic rats. J. Res. Med. Sci. 2011a;16:776-86.
3. Alam N, Yoon KN, Lee JS, Cho HJ, Shim MJ, Lee TS. Dietary effect of Pleurotus eryngii on biochemical function and histology in hypercholesterolemic rats. Saudi J. Biol. Sci. 2011b;18:403-9.
4. Alam N, Yoon KN, Lee TS, Lee UY. Hypolipidemic activities of dietary Pleurotus ostreatus in hypercholesterolemic rats. Mycobiology. 2011c;39:45-51.
5. Anandhi R, Annadurai T, Anitha TS, Muralidharan AR, Najmunnisha K, Nachiappan V, Thomas PA, Geraldine P. Antihypercholesterolemic and antioxidative effects of an extract of the oyster mushroom, Pleurotus ostreatus, and its major constituent, chrysin, in Triton WR-1339-induced hypercholesterolemic rats. J. Physiol. Biochem. 2013 Jun;69(2):313-23.
6. Atli B, Yamac M. Screening of medicinal higher Basidiomycetes mushrooms from Turkey for lovastatin production. Int. J. Med. Mushrooms. 2012;14:149-59.
7. Bajaj M, Vadhera S, Brar AP, Soni GL. Role of oyster mushroom (Pleurotus florida) as hypocholesterolemic/antiatherogenic agent. Indian J. Exp. Biol. 1997;35:1070-5.
8. Berger A, Rein D, Kratky E, Monnard I, Hajjaj H, Meirim I, Piguet-Welsch C, Hauser J, Mace K, Niederberger P. Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo, and in hamsters and minipigs. Lipids Health Dis. 2004;3:2.
9. Bobek P, Ozdín L, Kuniak L, Hromadová M. Regulation of cholesterol metabolism with dietary addition of oyster mushrooms (Pleurotus ostreatus) in rats with hypercholesterolemia. Cas Lek Cesk. 1997;136:186-90.
10. Bobek P, Ginter E, Jurcovicová M, Kuniak L. Cholesterol-lowering effect of the mushroom Pleurotus ostreatus in hereditary hypercholesterolemic rats. Ann. Nutr. Metab. 1991;35:191-5.
11. de Miranda AM, Ribeiro GM, Cunha AC, Silva LS, Dos Santos RC, Pedrosa ML,Silva ME. Hypolipidemic effect of the edible mushroom Agaricus blazei in rats subjected to a hypercholesterolemic diet. J. Physiol. Biochem. 2013 Nov 8. [Epub ahead of print].
12. Fukushima M, Ohashi T, Fujiwara Y, Sonoyama K, Nakano M. Cholesterol-lowering effects of maitake (Grifola frondosa) fiber, shiitake (Lentinus edodes) fiber, and enokitake (Flammulina velutipes) fiber in rats. Exp. Biol. Med. (Maywood). 2001;226:758-65.
13. Hu SH, Liang ZC, Chia YC, Lien JL, Chen KS, Lee MY, Wang JC. Antihyperlipidemic and antioxidant effects of extracts from Pleurotus citrinopileatus. J. Agric. Food Chem. 2006;54:2103-10.
14. Jeon BS, Park JW, Kim BK, Kim HK, Jung TS, Hahm JR, Kim DR, Cho YS, Cha JY. Fermented mushroom milk-supplemented dietary fibre prevents the onset of obesity and hypertriglyceridaemia in Otsuka Long-Evans Tokushima fatty rats. Diabetes Obes Metab. 2005;7:709-15.
15. Jeong SC, Jeong YT, Yang BK, Islam R, Koyyalamudi SR, Pang G, Cho KY, Song CH. White button mushroom (Agaricus bisporus) lowers blood glucose and cholesterol levels in diabetic and hypercholesterolemic rats. Nutr. Res. 2010;30(1):49-56.
16. Kanagasabapathy G, Malek SN, Mahmood AA, Chua KH, Vikineswary S, Kuppusamy UR.Beta-glucan-rich extract from Pleurotus sajor-caju (Fr.) Singer prevents obesity and oxidative stress in C57BL/6J mice fed on a high-fat diet. Evid Based Complement Alternat Med. 2013;2013:185259.
17. Khanna PK, Bhandari R, Soni GL, Singh CK, Garcha HS, Mittar D. Role of mushroom (Pleurotus florida) as hypocholesterolemic/hypolipidemic agent. Indian J. Exp. Biol. 1993;31:567-8.
18. Khan MA, Tania M, Liu R, Rahman MM. Hericium erinaceus: an edible mushroom with medicinal values. J. Complement Integr. Med. 2013 May 24;10.
19. Khatun K, Mahtab H, Khanam PA, Sayeed MA, Khan KA. Oyster mushroom reduced blood glucose and cholesterol in diabetic subjects. Mymensingh. Med. J. 2007;16:94-9.
20. Krasnopol'skaia LM, Kats NIu, Usov AI, Barkov AV, Vinokurov VA. Submerged cultivation of Lentinus edodes strain with broad spectrum biological activity. Antibiot Khimioter. 2012;57(9-10):3-7.
21. Li H, Zhang M, Ma G. Hypolipidemic effect of the polysaccharide from Pholiota nameko. Nutrition. 2010;26:556-62.
22. Mizutani T, Inatomi S, Inazu A, Kawahara E. Hypolipidemic effect of Pleurotus eryngii extract in fat-loaded mice. J. Nutr. Sci. Vitaminol. (Tokyo). 2010;56:48-53.
23. Mayell M. Maitake extracts and their therapeutic potential. Altern Med. Rev. 2001;6:48-60.
24. Mori K, Kobayashi C, Tomita T, Inatomi S, Ikeda M. Antiatherosclerotic effect of the edible mushrooms Pleurotus eryngii (Eringi), Grifola frondosa (Maitake), and Hypsizygus marmoreus (Bunashimeji) in apolipoprotein E-deficient mice. Nutr. Res. 2008;28:335-42.
25. Neyrinck AM, Bindels LB, De Backer F, Pachikian BD, Cani PD, Delzenne NM. Dietary supplementation with chitosan derived from mushrooms changes adipocytokine profile in diet-induced obese mice, a phenomenon linked to its lipid-lowering action. Int. Immunopharmacol. 2009;9:767-73.
26. Rokujo T, Kikuchi H, Tensho A, Tsukitani Y, Takenawa T, Yoshida K, Kamiya T. Lentysine: a new hypolipidemic agent from a mushroom. Life Sci. 1970;9:379-85.
27. Sugiyama K, Kawagishi H, Tanaka A, Saeki S, Yoshida S, Sakamoto H, Ishiguro Y. Isolation of plasma cholesterol-lowering components from ningyotake (Polyporus confluens) mushroom. J. Nutr. Sci. Vitaminol. (Tokyo). 1992;38:335-42.
28. Yamada T, Oinuma T, Niihashi M, Mitsumata M, Fujioka T, Hasegawa K, Nagaoka H, Itakura H. Effects of Lentinus edodes mycelia on dietary-induced atherosclerotic involvement in rabbit aorta. J. Atheroscler Thromb. 2002;9:149-56.
29. Yang BK, Park JB, Song CH. Hypolipidemic effect of an exo-biopolymer produced from a submerged mycelial culture of Hericium erinaceus. Biosci. Biotechnol. Biochem. 2003;67:1292-8.
30. Yang H, Hwang I, Kim S, Hong EJ, Jeung EB. Lentinus edodes promotes fat removal in hypercholesterolemic mice. Exp. Ther. Med. 2013;6:1409-1413.
31. Yang uK, Jeong SC, Lee HJ, Sohn DH, Song CH. Antidiabetic and hypolipidemic effects of Collybia confluens mycelia produced by submerged culture instreptozotocin-diabetic rats. Arch. Pharm. Res. 2006;29:73-9.
32. Yoon KN, Alam N, Lee JS, Cho HJ, Kim HY, Shim MJ, Lee MW, Lee TS. Antihyperlipidemic Effect of dietary Lentinus edodes on plasma, feces and hepatic tissues in hypercholesterolemic rats. Mycobiology. 2011b;39:96-102.
33. Yoon KN, Alam N, Shim MJ, Lee TS. Hypolipidemic and antiatherogenesis effect of culinary-medicinal pink oyster mushroom, Pleurotus salmoneostramineus L. Vass. (higher Basidiomycetes), in hypercholesterolemic rats. Int. J. Med. Mushrooms. 2012;14(1):27-36.
34. Yoon KN, Lee JS, Kim HY, Lee KR, Shin PG, Cheong JC, Yoo YB, Alam N, Ha TM, Lee TS. Appraisal of antihyperlipidemic activities of Lentinus lepideus in hypercholesterolemic rats. Mycobiology. 2011a;39:283-9.